Valkyrie Clinical Trials
- Company typePrivate
- Founded2021
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Valkyrie Clinical Trials firmographics
Firmographics- Name
- Valkyrie Clinical Trials
- Legal name
- Valkyrie Clinical Trials
- Website
- https://valkyrieclinicaltrials.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Valkyrie Clinical Trials industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (6223)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)
Keywords
Where Valkyrie Clinical Trials is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Valkyrie Clinical Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Services: Valkyrie generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. The company operates clinical research sites that enroll and manage cancer patients participating in clinical studies, receiving compensation from sponsors for study execution, patient recruitment, and data collection services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Valkyrie Clinical Trials product offering
Product offeringCore offering
Valkyrie Clinical Trials is a clinical research site organization that conducts oncology-focused clinical trials on behalf of pharmaceutical and biotech sponsors across 21+ cancer types. It operates three physical trial sites in Southern California (Century City, Murrieta, Panorama City), providing end-to-end clinical research services including participant eligibility consultations, no-cost assessments, one-to-one clinical research coordinator support, transportation coordination, and specialized inpatient trial facilities. Revenue is generated from sponsors for study execution, patient recruitment, and data collection services.
Product overview
Valkyrie Clinical Trials is a clinical research services company focused on oncology, operating as a Flourish Research company. The offering consists of clinical trial services spanning multiple cancer types, supported by clinical trial sites in Southern California. Services include eligibility consultations, no-cost participant assessments, and one-to-one coordinator support throughout the trial journey. The company operates sites in Century City, Murrieta, and Panorama City, serving a diverse patient population across multiple languages including English, Spanish, German, Russian, Ukrainian, Vietnamese, Japanese, and Tagalog.
Differentiator
Problem solved
Functional benefit
Products and services
- Oncology Clinical Research Services End-to-end oncology clinical research services offered to pharmaceutical and biotech sponsors, including eligibility consultations, no-cost participant assessments, one-to-one clinical research coordinator support, scheduling of imaging and lab work, follow-up appointment coordination, and transportation arrangement to and from clinic visits.
- Clinical Trial Sites (Southern California) Three physical clinical trial sites located in Century City (2080 Century Park E Suite 803, Los Angeles, CA 90067), Murrieta (25405 Hancock Ave Suite 110, Murrieta, CA 92562), and Panorama City (14850 Roscoe Blvd, Panorama City, CA 91402), including a highly specialized clinical trial inpatient unit providing enhanced comfort and discretion for participants.
Companies that use Valkyrie Clinical Trials
Customer profileSegments2 records
Ideal customer profiles1 record
Valkyrie Clinical Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Valkyrie Clinical Trials partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Flourish ResearchcoreFlourish Research established a strategic partnership with Valkyrie Clinical Trials in October 2025 to expand access to oncology-focused clinical trials and strengthen its presence in Southern California. Valkyrie operates as a Flourish Research company, leveraging the partnership to provide patients with access to groundbreaking cancer therapies and support sponsors with research in novel treatments.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Valkyrie Clinical Trials competitors and assessment
Company assessmentDirect peers
- Florida Cancer Specialists & Research Institute: Community oncology practice that runs an extensive clinical trial program including Phase I studies; matches Valkyrie's blend of oncology practice + dedicated clinical research operations.
- NEXT Oncology: Specialized Phase I oncology clinical trial site network offering early-phase cancer trials to pharma sponsors; closely comparable to Valkyrie's Phase I/IIa orientation and inpatient unit capability.
- Sarah Cannon Research Institute: One of the largest oncology-focused clinical trial site networks in the U.S., running Phase I–III oncology studies across multiple cancer types — directly comparable to Valkyrie's oncology clinical research site model at much larger scale.
Broad incumbents
- US Oncology Research: Affiliated with The US Oncology Network and supported by McKesson, operates a large community-based oncology clinical trial program across hundreds of sites — comparable oncology trial execution model but at vastly greater scale.
- Cedars-Sinai Medical Center (Clinical Trials Office): Major Los Angeles academic medical center with an extensive oncology clinical trial portfolio; competes with Valkyrie for SoCal oncology patients and sponsor studies, especially Phase I/IIa.
- Texas Oncology: Large community-based oncology practice operating a substantial clinical research program across Texas; comparable oncology specialty + trial execution model with broader geographic footprint.
- IQVIA (Oncology Clinical Trials): Global CRO with a major oncology clinical trial practice that runs and supports oncology studies end-to-end; broader scope than Valkyrie but a frequent counterpart/customer for site-based oncology research.
- City of Hope (Clinical Trials): NCI-designated comprehensive cancer center near Los Angeles running a large portfolio of oncology trials; a direct competitor for SoCal oncology trial patients and early-phase sponsors.
Emerging players
- Massive Bio: AI-driven oncology clinical trial matching platform connecting cancer patients to trial sites — adjacent to Valkyrie's mission of expanding equitable access to oncology trials, though operating as a tech-enabled intermediary rather than a site.
Regional players
- Innovative Clinical Research (part of Hoag): Southern California-based oncology clinical research program affiliated with a regional health system; comparable regional SoCal site network serving pharma-sponsored oncology trials.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Valkyrie Clinical Trials social profiles
Digital presenceValkyrie Clinical Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Valkyrie Clinical Trials leadership team
Management profileNumber of profiles
Profiles2 records
Valkyrie Clinical Trials funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Valkyrie Clinical Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Valkyrie Clinical Trials
What does Valkyrie Clinical Trials do?
Valkyrie Clinical Trials is a clinical research site organization that conducts oncology-focused clinical trials on behalf of pharmaceutical and biotech sponsors across 21+ cancer types. It operates three physical trial sites in Southern California (Century City, Murrieta, Panorama City), providing end-to-end clinical research services including participant eligibility consultations, no-cost assessments, one-to-one clinical research coordinator support, transportation coordination, and specialized inpatient trial facilities. Revenue is generated from sponsors for study execution, patient recruitment, and data collection services.
Is Valkyrie Clinical Trials a public or private company?
Valkyrie Clinical Trials is a private company. It is classified as corporate owned and is currently operating.
When was Valkyrie Clinical Trials founded?
Valkyrie Clinical Trials was founded in 2021. It employs 11 to 50 people.
Where is Valkyrie Clinical Trials based?
Valkyrie Clinical Trials is headquartered in Los Angeles, United States, in the North America region.
How does Valkyrie Clinical Trials make money?
One revenue line is on record: clinical Trial Services.
Who are Valkyrie Clinical Trials's main competitors?
Direct peers on record are Florida Cancer Specialists & Research Institute, NEXT Oncology and Sarah Cannon Research Institute. Broad incumbents are US Oncology Research, Cedars-Sinai Medical Center (Clinical Trials Office), Texas Oncology, IQVIA (Oncology Clinical Trials) and City of Hope (Clinical Trials). Massive Bio is listed as an emerging player. Innovative Clinical Research (part of Hoag) is listed as a regional player.
Does Valkyrie Clinical Trials have an API?
No public API is recorded for Valkyrie Clinical Trials.
What industry is Valkyrie Clinical Trials in?
Valkyrie Clinical Trials's product category is Clinical Research Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 6223 and its SIC code is 8011.